1. Home
  2. ANIX vs MRCC Comparison

ANIX vs MRCC Comparison

Compare ANIX & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.83

Market Cap

104.0M

Sector

Health Care

ML Signal

HOLD

Logo Monroe Capital Corporation

MRCC

Monroe Capital Corporation

HOLD

Current Price

$5.08

Market Cap

100.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIX
MRCC
Founded
1982
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
104.0M
100.1M
IPO Year
2013
2011

Fundamental Metrics

Financial Performance
Metric
ANIX
MRCC
Price
$2.83
$5.08
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$8.67
N/A
AVG Volume (30 Days)
103.6K
123.6K
Earning Date
05-27-2026
05-06-2026
Dividend Yield
N/A
7.09%
EPS Growth
12.82
N/A
EPS
N/A
N/A
Revenue
$210,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.44
$4.11
52 Week High
$5.46
$7.76

Technical Indicators

Market Signals
Indicator
ANIX
MRCC
Relative Strength Index (RSI) 53.40 52.95
Support Level $2.74 $4.44
Resistance Level $3.10 $6.77
Average True Range (ATR) 0.16 0.24
MACD 0.04 0.09
Stochastic Oscillator 80.61 71.19

Price Performance

Historical Comparison
ANIX
MRCC

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

About MRCC Monroe Capital Corporation

Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the United States and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants. Its investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through investment in senior secured, unitranche secured and junior secured debt and, to a lesser extent, unsecured subordinated debt and equity investments.

Share on Social Networks: